Showing results (21-30 of 226) with videos related to
Sort By:
Pageof 23
Rheumatology (Oxford, England)|September 15, 2012
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblastsXu Shi-wen, Katherine Thompson, Korsa Khan, et al.Journal of Cell Communication and Signaling|May 15, 2020
COVID-19: is fibrosis the killer?Andrew LeaskJournal of Cell Communication and Signaling|April 13, 2011
Will o' the wisp: CCN4 as a novel molecular target in osteoarthritisAndrew LeaskThe Journal of Investigative Dermatology|April 14, 2012
Toward personalized medicine in scleroderma: classification of scleroderma patients into stable "inflammatory" and "fibrotic" subgroupsAndrew LeaskJournal of Cell Communication and Signaling|July 13, 2011
Eureka! Ets a target for fibrosis!Andrew LeaskJournal of Cell Communication and Signaling|February 19, 2009
Hijacking ZIP codes: posttanscriptional regulation of CCN2 by nucleophosminAndrew LeaskCirculation Research|June 12, 2010
Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activationAndrew LeaskFibrogenesis & Tissue Repair|May 29, 2010
Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitmentAndrew LeaskJournal of Cell Communication and Signaling|May 29, 2009
Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2Andrew LeaskJournal of Cell Communication and Signaling|November 11, 2010
Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2Andrew LeaskPageof 23